InvestorsHub Logo
Followers 14
Posts 733
Boards Moderated 0
Alias Born 12/09/2013

Re: vinmantoo post# 2051

Thursday, 10/07/2021 4:54:22 PM

Thursday, October 07, 2021 4:54:22 PM

Post# of 3015
Congrats! I started adding in March, then share price dropped again which was a bonus. I closed another position in order to add.
Then the Hep B data came out, then covid- which seemed to validate my feelings.

Much of Enanta's pipeline will come into greater focus next year. So like you I rather wished it would stay down a bit longer.

At issue with covid- there are still huge numbers who aren't or won't get vaccinated AND data is showing the need for boosters, increasing proof that immunity isn't forever, etc.
So the need for an antiviral/theraputic is great.

What I am seeing is that the Pfizer PI has some issues (twice daily w/ R boosting), and the Merck is also not free of risk-regardless of the recent positive buzz. Do I think ENTA can create a superior PI to Pfizer's? Yes.
The ATI/Roche compound looks good/interesting and they say their nuke will be resistant to mutation vrs a PI, but we are looking at a 5-7 day treatment- so resistance may not be an issue. It may be more possible/likely to create a successful PI than a nuke but we will see.

IF the Hep B data gets digested and holds in trials the Jeffrie's 95 dollar target will be low.


I cannot imagine Enanta's market cap w/ a successful drug(s) in HBV, Covid and RSV; well over $95, I'd wager.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News